The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

The Department of Health and Human Services seeks to expand when Medicare and Medicaid can cover anti-obesity drugs, such as ...

A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...

The Biden administration has announced a new proposal to include weight-loss drugs under Medicare and Medicaid programmes. While the plan will help more than seven million Americans struggling with ...

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...

The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) ...

Last, the administration's proposal also tries to shore up guardrails for the use of AI in health care with edits to existing ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by ...

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...